Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension

Overview

Journal Front Pharmacol

Date 2020 Jun 9

PMID 32508639

Citations 8

Authors

Ya-Ru Bao

Jing-Wei Chen

Yan Jiang

Lin-Hui Wang

Rong Xue

Jin-Xian Qian

Guo-Xing Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Pulmonary hypertension (PH) remains a prevalent disease globally. Sodium tanshinone II sulfonate A (STS) has been used in clinical treatment of PH.

Aims: The aim of the present study was to investigate the effect of sodium STS treatment on hypoxia-induced PH and related mechanisms.

Methods: Male Sprague-Dawley rats were housed in a hypoxic chamber with an oxygen concentration of 10 ± 1% for 8 h a day over 21 days. Rats were treated with either STS (low-dose: 10 mg/kg or high-dose: 30 mg/kg) or LY294002 (which is an inhibitor of PI3K). Pulmonary arterial pressure (PAP) was measured, right ventricular hypertrophy parameters were monitored, lung edema parameters were measured, and pathological changes were observed by hematoxylin-eosin (HE) staining. Protein expressions of apoptosis, and PI3K/AKT/mTOR/autophagy pathways in rat lung tissue were examined by western blot. Levels of the pro-inflammatory factors IL-6, IL-8, TNF-α in lung tissues of rats were measured using an enzyme linked immunosorbent assay (ELISA).

Results: Results of our study demonstrate that persistent exposure to hypoxic conditions increased PAP, right ventricular hypertrophy, lung edema, parameters of lung vascular proliferation and decreased the ratio of Bax/Bcl-2. Furthermore, hypoxic conditions activated the PI3K/Akt/mTOR pathway, inhibited autophagy, and elevated abundance of inflammatory factors in rat lung tissue. Treatment with STS resulted in a dose-dependent decrease in PAP, right ventricular hypertrophy, lung edema, lung vascular proliferation and reversed hypoxia induced lung tissue protein expression and pro-inflammatory factors in rat lung tissue. In addition, hypoxia-induced increases in PAP, cardiac hypertrophy, and lung expression of the proteins PI3K/Akt/mTOR/autophagy pathway were partially reversed by treatment with LY294002.

Conclusions: STS alleviates hypoxia-induced PH by promoting apoptosis, inhibiting PI3K/AKT/mTOR pathway, up-regulating autophagy, and inhibiting inflammatory responses.

Citing Articles

Progress of tanshinone IIA against respiratory diseases: therapeutic targets and potential mechanisms.

Ding Z, Deng Y, Luo H, Liu C, Yang M, Xue H Front Pharmacol. 2025; 16:1505672.

PMID: 40066338 PMC: 11891354. DOI: 10.3389/fphar.2025.1505672.

Halofuginone prevents inflammation and proliferation of high-altitude pulmonary hypertension by inhibiting the TGF-β1/Smad signaling pathway.

Wang J, Guan L, Yu J, Ma B, Shen H, Xing G Sci Rep. 2025; 15(1):3619.

PMID: 39880976 PMC: 11779860. DOI: 10.1038/s41598-025-88258-z.

OPN silencing reduces hypoxic pulmonary hypertension via PI3K-AKT-induced protective autophagy.

Zhou R, Li R, Ding Q, Zhang Y, Yang H, Han Y Sci Rep. 2024; 14(1):8670.

PMID: 38622371 PMC: 11018812. DOI: 10.1038/s41598-024-59367-y.

Vitamin D3 improved hypoxia-induced lung injury by inhibiting the complement and coagulation cascade and autophagy pathway.

Dai C, Lin X, Qi Y, Wang Y, Lv Z, Zhao F BMC Pulm Med. 2024; 24(1):9.

PMID: 38166725 PMC: 10759436. DOI: 10.1186/s12890-023-02784-y.

TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats.

Shi H, Zhao Y, Li S, Wu H, Ma D, Wan C Open Life Sci. 2023; 18(1):20220650.

PMID: 37528886 PMC: 10389672. DOI: 10.1515/biol-2022-0650.

References

Wang J, Lu W, Wang W, Zhang N, Wu H, Liu C . Promising therapeutic effects of sodium tanshinone IIA sulfonate towards pulmonary arterial hypertension in patients. J Thorac Dis. 2013; 5(2):169-72. PMC: 3621926. DOI: 10.3978/j.issn.2072-1439.2013.02.04. View

Zhu J, Xu Y, Ren G, Hu X, Wang C, Yang Z . Tanshinone IIA Sodium sulfonate regulates antioxidant system, inflammation, and endothelial dysfunction in atherosclerosis by downregulation of CLIC1. Eur J Pharmacol. 2017; 815:427-436. DOI: 10.1016/j.ejphar.2017.09.047. View

Tanaka A, Jin Y, Lee S, Zhang M, Kim H, Stolz D . Hyperoxia-induced LC3B interacts with the Fas apoptotic pathway in epithelial cell death. Am J Respir Cell Mol Biol. 2011; 46(4):507-14. PMC: 3359946. DOI: 10.1165/rcmb.2009-0415OC. View

Li L, Wang X, Wang L, Qu L, Zhu X, Li M . Mammalian target of rapamycin overexpression antagonizes chronic hypoxia-triggered pulmonary arterial hypertension via the autophagic pathway. Int J Mol Med. 2015; 36(1):316-22. DOI: 10.3892/ijmm.2015.2224. View

Zhou G, Jiang W, Zhao Y, Ma G, Xin W, Yin J . Sodium tanshinone IIA sulfonate mediates electron transfer reaction in rat heart mitochondria. Biochem Pharmacol. 2002; 65(1):51-7. DOI: 10.1016/s0006-2952(02)01447-8. View

Pan Y, Qian J, Lu S, Chen J, Zhao X, Jiang Y . Protective effects of tanshinone IIA sodium sulfonate on ischemia-reperfusion-induced myocardial injury in rats. Iran J Basic Med Sci. 2017; 20(3):308-315. PMC: 5378969. DOI: 10.22038/ijbms.2017.8361. View

Young J, Williams D, Thompson A . Thin Air, Thick Vessels: Historical and Current Perspectives on Hypoxic Pulmonary Hypertension. Front Med (Lausanne). 2019; 6:93. PMC: 6504829. DOI: 10.3389/fmed.2019.00093. View

Kourembanas S, Marsden P, McQuillan L, Faller D . Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest. 1991; 88(3):1054-7. PMC: 295521. DOI: 10.1172/JCI115367. View

Strange G, Playford D, Stewart S, Deague J, Nelson H, Kent A . Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart. 2012; 98(24):1805-11. PMC: 3533383. DOI: 10.1136/heartjnl-2012-301992. View

10.

Yang R, Liu A, Ma X, Li L, Su D, Liu J . Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation. J Cardiovasc Pharmacol. 2008; 51(4):396-401. DOI: 10.1097/FJC.0b013e3181671439. View

11.

Weigand L, Shimoda L, Sylvester J . Enhancement of myofilament calcium sensitivity by acute hypoxia in rat distal pulmonary arteries. Am J Physiol Lung Cell Mol Physiol. 2011; 301(3):L380-7. PMC: 3174742. DOI: 10.1152/ajplung.00068.2011. View

12.

Gall H, Felix J, Schneck F, Milger K, Sommer N, Voswinckel R . The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups. J Heart Lung Transplant. 2017; 36(9):957-967. DOI: 10.1016/j.healun.2017.02.016. View

13.

Xu Y, Sun Z, Wang Q, Wang T, Liu Y, Yu F . Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway. Vascul Pharmacol. 2019; 120:106568. DOI: 10.1016/j.vph.2019.106568. View

14.

Dunham-Snary K, Wu D, Sykes E, Thakrar A, Parlow L, Mewburn J . Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine. Chest. 2016; 151(1):181-192. PMC: 5310129. DOI: 10.1016/j.chest.2016.09.001. View

15.

Bailey D, Dehnert C, Luks A, Menold E, Castell C, Schendler G . High-altitude pulmonary hypertension is associated with a free radical-mediated reduction in pulmonary nitric oxide bioavailability. J Physiol. 2010; 588(Pt 23):4837-47. PMC: 3010150. DOI: 10.1113/jphysiol.2010.194704. View

16.

Simonneau G, Montani D, Celermajer D, Denton C, Gatzoulis M, Krowka M . Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2018; 53(1). PMC: 6351336. DOI: 10.1183/13993003.01913-2018. View

17.

Lu W, Kang J, Hu K, Tang S, Zhou X, Xu L . The role of the Nox4-derived ROS-mediated RhoA/Rho kinase pathway in rat hypertension induced by chronic intermittent hypoxia. Sleep Breath. 2017; 21(3):667-677. DOI: 10.1007/s11325-016-1449-2. View

18.

Li X, Lu X, Zhang S, Chiu A, Lo L, Largaespada D . Sodium tanshinone IIA sulfonate ameliorates hepatic steatosis by inhibiting lipogenesis and inflammation. Biomed Pharmacother. 2018; 111:68-75. DOI: 10.1016/j.biopha.2018.12.019. View

19.

Li Y, Ren W, Wang X, Yu X, Cui L, Li X . MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension. Biomed Pharmacother. 2018; 109:1740-1749. DOI: 10.1016/j.biopha.2018.11.058. View

20.

Ibe J, Zhou Q, Chen T, Tang H, Yuan J, Raj J . Adenosine monophosphate-activated protein kinase is required for pulmonary artery smooth muscle cell survival and the development of hypoxic pulmonary hypertension. Am J Respir Cell Mol Biol. 2013; 49(4):609-18. PMC: 3824043. DOI: 10.1165/rcmb.2012-0446OC. View